Diabetes drug

MannKind Corp. of Valencia is seeking Food and Drug Administration approval of its inhaled diabetes medication, Afrezza.
Damion Edwards / MannKind Corp.
Copyright © 2017, Los Angeles Times
EDITION: California | U.S. & World
70°